MATTER partners with Roche Diabetes Care to source solutions for diabetes-related complications and comorbidities
The partners unveil a startup challenge to improve the quality of life for those living with diabetes.
Chicago, IL, April 7, 2021 — MATTER, the premier healthcare incubator and innovation hub, today announced a partnership with Roche Diabetes Care, a global leader in integrated Personalized Diabetes Management (iPDM), to host the 2021 Roche Diabetes Care Innovation Challenge. The challenge will source solutions that help people living with diabetes assess and monitor diabetes-related complications and limit risk progression.
“We’ve learned from people with diabetes that they struggle with managing and reducing their individual risk for diabetes-related complications, in the hopes of ultimately avoiding them”, said Marco de Polo, Head of Strategic Insights & Open Innovation at Roche Diabetes Care. “Now in our second year of the Innovation Challenge, we are excited to build on our success from last year, and look forward to collaborating with startups who can help address these challenges innovatively and effectively, and bring true relief to patients with diabetes.”
One of the main challenges for people living with diabetes, and for providers and payers is developing a strategic plan to successfully assess, monitor and manage diabetes-related risks such as cardiovascular diseases, diabetic retinopathy and kidney disease. The 2021 Roche Diabetes Care Innovation Challenge is looking to accelerate novel solutions that effectively monitor an individual’s risk of developing diabetes-related complications, or empower individuals and their providers to manage that risk order to slow, stop or reverse the risk progression.
“Together with Roche Diabetes Care, we will bring together leaders in the space to partner with entrepreneurs to develop and scale solutions to improve the lives of people living with diabetes,” said Steven Collens, CEO of MATTER. “Our innovation program will identify the most promising technologies from around the world and accelerate their progress so they can reach and help more people living with diabetes.”
Together with Roche Diabetes Care, we will bring together leaders in the space to partner with entrepreneurs to develop and scale solutions to improve the lives of people living with diabetes. — Steven Collens, CEO of MATTER
After the submission deadline, eight to twelve semi-finalists will be chosen to take part in an incubation phase where they will engage with Roche Diabetes Care experts and MATTER mentors. The incubation phase will culminate in a virtual pitch day the week of July 12, 2021 where semi-finalists will present their solutions to Roche Diabetes Care executives and the MATTER community. Following the event, three to five finalists will be selected to progress to the accelerator phase where they will have the opportunity to develop and pitch their pilot proposal. The winning startup will receive $20,000 from Roche Diabetes Care and a one-year membership with MATTER.
Interested companies can learn more and apply by visiting the challenge website. Applications are due by May 26, 2021 at 11:59pm CST. To learn more about Roche Diabetes Care focus areas and how to apply to the challenge, join us on Thursday May 6, 2021 for an event with the program sponsors.
About Roche Diabetes Care
Roche Diabetes Care has been pioneering innovative diabetes technologies and services for more than 40 years. More than 5,500 employees in over 100 markets worldwide work every day to support people with diabetes and those at risk to achieve more time in their target ranges and experience true relief from the daily therapy routines.
Being a global leader in integrated Personalized Diabetes Management (iPDM), Roche Diabetes Care collaborates with thought leaders around the globe, including people with diabetes, caregivers, healthcare providers and payers. Roche Diabetes Care aims to transform and advance care provision and foster sustainable care structures. Under the brands RocheDiabetes, Accu-Chek and mySugr, comprising glucose monitoring, insulin delivery systems and digital solutions, Roche Diabetes Care unites with its partners to create patient-centred value. By building and collaborating in an open ecosystem, connecting devices and digital solutions as well as contextualising relevant data points, Roche Diabetes Care enables deeper insights and a better understanding of the disease, leading to personalised and effective therapy adjustments. For better outcomes and true relief.
Since 2017, mySugr, one of the most popular diabetes management apps, is part of Roche Diabetes Care.
All trademarks used or mentioned in this release are protected by law.
At MATTER, we believe collaboration is the best way to improve healthcare. The MATTER collaborative includes more than 300 cutting-edge startups from around the world, working together with dozens of hospitals and health systems, universities and industry-leading companies to build the future of healthcare. Together we are accelerating innovation, advancing care and improving lives. For more information, visit matter.health and follow @MATTERhealth.